SH3TC2 and colorectal carcinoma: Considering that SH3TC2 showed an obviously high expression status in CRC (COAD and READ, Figures 1(c) and 1(f)), we further included four CRC cohorts (GSE9348, GSE32323, GSE21510, and GSE39582) from the GEO database to verify SH3TC2 expression.